181 related articles for article (PubMed ID: 35733916)
1. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.
Shen T; Zhang J; Wang Y; Liu B
J Immunol Res; 2022; 2022():8443392. PubMed ID: 35733916
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment.
Ding Q; Lin F; Huang Z; Li Y; Cai S; Chen X; Liu H; Qiu S
Sci Rep; 2024 Feb; 14(1):4426. PubMed ID: 38396056
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
4. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
5. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
[TBL] [Abstract][Full Text] [Related]
6. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
7. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel 7 immune-related genes prognostic model for oral cancer: A study based on TCGA database.
Zhao XT; Zhu Y; Zhou JF; Gao YJ; Liu FZ
Oral Oncol; 2021 Jan; 112():105088. PubMed ID: 33220636
[TBL] [Abstract][Full Text] [Related]
9. Identification of Candidate Target Genes and Immune Cells in Oral Squamous Cell Carcinoma.
Xie P; Wu S; Guo L; Ren J; Cai K; Zhou M; Liu W; Yang S
Comput Math Methods Med; 2021; 2021():5802110. PubMed ID: 35003322
[TBL] [Abstract][Full Text] [Related]
10. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
11. Triggering receptor expressed in myeloid cells 1 (TREM1) as a potential prognostic biomarker and association with immune infiltration in oral squamous cell carcinoma.
Kannan B; Pandi C; Pandi A; Jayaseelan VP; Arumugam P
Arch Oral Biol; 2024 May; 161():105926. PubMed ID: 38442472
[TBL] [Abstract][Full Text] [Related]
12. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
13. [IgG Fc binding protein (FCGBP) as a prognostic marker of low-grade glioma and its correlation analysis with immune infiltration].
Liu Q; Zhang J; Zhang F; Zhang W; Gong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):686-692. PubMed ID: 37515334
[TBL] [Abstract][Full Text] [Related]
14. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
Shen Q; Xiong P; Yang D; Chen L
Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
Zhang YY; Mao MH; Han ZX
Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
[TBL] [Abstract][Full Text] [Related]
16.
Yang Z; Yan G; Zheng L; Gu W; Liu F; Chen W; Cui X; Wang Y; Yang Y; Chen X; Fu Y; Xu X
Oncoimmunology; 2021 Jun; 10(1):1938890. PubMed ID: 34221701
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W
Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296
[TBL] [Abstract][Full Text] [Related]
18. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
19. Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma.
Lin YH; Yang YF; Shiue YL
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626334
[TBL] [Abstract][Full Text] [Related]
20. Identification of diagnostic and prognostic lncRNA biomarkers in oral squamous carcinoma by integrated analysis and machine learning.
Yang S; Wang Y; Ren J; Zhou X; Cai K; Guo L; Wu S
Cancer Biomark; 2020; 29(2):265-275. PubMed ID: 32716346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
